Xylem Inc (XYL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the XYL SEC filings page.
Xylem Inc (XYL) reported $9.1B in revenue over the twelve months to Jun 30, 2026, up 4.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Xylem’s recent growth is paired with expanding margins and cash generation, while its balance sheet has become increasingly goodwill-heavy.
The FY2023–FY2025 period pairs growth with operating-margin expansion, from8.9% to13.5% , showing that more sales are reaching operating profit rather than growth being consumed by costs. Yet cash conversion weakened at the margin: free cash flow slipped to$910M in FY2025 while net income rose, so the latest earnings improvement did not produce more cash after reinvestment.
The FY2023 balance-sheet step-up left goodwill at
Capital expenditures absorbed roughly
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Xylem Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Xylem Inc has an operating margin of 13.5%, meaning the company retains $14 of operating profit per $100 of revenue. This strong profitability earns a score of 76/100, reflecting efficient cost management and pricing power. This is up from 11.8% the prior year.
Xylem Inc's revenue grew 5.5% year-over-year to $9.0B, a solid pace of expansion. This earns a growth score of 67/100.
Xylem Inc carries a low D/E ratio of 0.12, meaning only $0.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.
Xylem Inc's current ratio of 1.63 indicates adequate short-term liquidity, earning a score of 47/100. The company can meet its near-term obligations, though with limited headroom.
Xylem Inc converts 10.1% of revenue into free cash flow ($910.0M). This strong cash generation earns a score of 65/100.
Xylem Inc's ROE of 8.3% shows moderate profitability relative to equity, earning a score of 63/100. This is down from 8.4% the prior year.
Xylem Inc scores 3.60, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($24.0B) relative to total liabilities ($5.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Xylem Inc passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Xylem Inc generates $1.30 in operating cash flow ($1.2B OCF vs $957.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Xylem Inc earns $42.17 in operating income for every $1 of interest expense ($1.2B vs $29.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Xylem Inc generated $2.3B in revenue in Q2 2026. This represents an increase of 1.5% from the same quarter a year earlier. Against the prior quarter it is up 9.9%.
Xylem Inc's EBITDA was $530.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 17.8% from the same quarter a year earlier. Against the prior quarter it is up 38.0%.
Xylem Inc reported $263.0M in net income in Q2 2026. This represents an increase of 16.4% from the same quarter a year earlier. Against the prior quarter it is up 36.3%.
Xylem Inc earned $1.11 per diluted share (EPS) in Q2 2026. This represents an increase of 19.4% from the same quarter a year earlier. Against the prior quarter it is up 40.5%.
Cash & Balance Sheet
Xylem Inc generated $201.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 2.9% from the same quarter a year earlier. Against the prior quarter it is up 1016.7%.
Xylem Inc held $1.3B in cash against $2.4B in long-term debt as of Q2 2026.
Xylem Inc paid $0.43 per share in dividends in Q2 2026. This represents an increase of 7.5% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Xylem Inc's gross margin was 41.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.4 percentage points.
Xylem Inc's operating margin was 16.7% in Q2 2026, reflecting core business profitability. This is up 3.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.2 percentage points.
Xylem Inc's net profit margin was 11.3% in Q2 2026, showing the share of revenue converted to profit. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.
Xylem Inc's ROE was 2.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.
Capital Allocation
Xylem Inc invested $59.0M in research and development in Q2 2026. This represents an increase of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 5.4%.
Xylem Inc spent $680.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is up 20.8%.
Xylem Inc invested $89.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 9.2% from the same quarter a year earlier. Against the prior quarter it is down 1.1%.
XYL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B+1.5% | $2.1B+2.7% | $2.4B+6.3% | $2.3B+7.8% | $2.3B+6.1% | $2.1B+1.8% | $2.3B+6.5% | $2.1B+1.3% |
| Cost of Revenue | $1.4B-2.6% | $1.3B+1.6% | $1.5B+4.7% | $1.4B+4.9% | $1.4B+4.4% | $1.3B+1.6% | $1.4B+2.7% | $1.3B+0.6% |
| Gross Profit | $963.0M+8.0% | $803.0M+4.6% | $932.0M+8.8% | $883.0M+12.6% | $892.0M+8.9% | $768.0M+2.1% | $857.0M+13.4% | $784.0M+2.6% |
| R&D Expenses | $59.0M+1.7% | $56.0M0.0% | $60.0M+3.4% | $52.0M-5.5% | $58.0M0.0% | $56.0M-5.1% | $58.0M-3.3% | $55.0M-9.8% |
| SG&A Expenses | $503.0M0.0% | $472.0M+2.6% | $486.0M-4.1% | $474.0M+6.5% | $503.0M+3.7% | $460.0M-3.0% | $507.0M+8.8% | $445.0M-9.4% |
| Operating Income | $390.0M+27.9% | $244.0M+5.6% | $353.0M+32.2% | $334.0M+19.3% | $305.0M+20.6% | $231.0M+10.5% | $267.0M+26.5% | $280.0M+46.6% |
| EBITDA | $530.0M+17.8% | $384.0M+2.1% | $496.0M+21.3% | $476.0M+13.1% | $450.0M+13.1% | $376.0M+9.6% | $409.0M+17.5% | $421.0M+24.6% |
| Interest Expense | $7.0M-22.2% | $4.0M-50.0% | $6.0M-33.3% | $6.0M-40.0% | $9.0M-18.2% | $8.0M-42.9% | $9.0M-35.7% | $10.0M-28.6% |
| Income Tax | $103.0M+37.3% | $55.0M+10.0% | $35.0M-28.6% | $71.0M+36.5% | $75.0M+41.5% | $50.0M+16.3% | $49.0M+187.5% | $52.0M+57.6% |
| Net Income | $263.0M+16.4% | $193.0M+14.2% | $335.0M+2.8% | $227.0M+4.6% | $226.0M+16.5% | $169.0M+10.5% | $326.0M+22.6% | $217.0M+42.8% |
| EPS (Basic) | $1.11+19.4% | $0.79+14.5% | $1.37+2.2% | $0.93+4.5% | $0.93+16.3% | $0.69+9.5% | $1.34+14.5% | $0.89+41.3% |
| EPS (Diluted) | $1.11+19.4% | $0.79+14.5% | $1.37+3.0% | $0.93+4.5% | $0.93+16.3% | $0.69+9.5% | $1.33+14.7% | $0.89+41.3% |
| Diluted Shares (Avg) | 237M-3.0% | 243M-0.2% | N/A | 244M+0.1% | 244M+0.1% | 244M+0.3% | N/A | 244M+0.6% |
XYL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.3B+0.9% | $17.0B+2.4% | $17.6B+6.9% | $17.3B+7.8% | $17.2B+9.0% | $16.6B+4.0% | $16.5B+2.4% | $16.0B+0.9% |
| Current Assets | $4.4B+0.6% | $4.0B-1.3% | $4.6B+13.3% | $4.4B+10.7% | $4.4B+15.6% | $4.1B+4.9% | $4.1B+5.5% | $4.0B+9.9% |
| Cash & Equivalents | $1.3B+9.1% | $808.0M-23.7% | $1.5B+31.9% | $1.2B+20.4% | $1.2B+43.6% | $1.1B+11.8% | $1.1B+10.0% | $989.0M+40.3% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $1.0B-5.1% | $991.0M-3.0% | $983.0M-1.3% | $1.0B-5.1% | $1.1B+1.3% | $1.0B-1.6% | $996.0M-2.2% | $1.1B+1.0% |
| Accounts Receivable | $1.9B+2.1% | $1.8B+3.0% | $1.8B+5.5% | $1.8B+5.6% | $1.8B+9.7% | $1.7B+6.2% | $1.7B+3.2% | $1.7B+3.3% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $8.3B+0.2% | $8.3B+2.9% | $8.3B+4.4% | $8.3B+9.0% | $8.2B+9.7% | $8.1B+7.4% | $8.0B+5.2% | $7.6B+6.2% |
| Total Liabilities | $6.7B+13.5% | $5.7B+4.0% | $5.9B+4.9% | $5.8B+7.4% | $5.9B+8.6% | $5.5B-3.8% | $5.6B-5.5% | $5.4B-8.7% |
| Current Liabilities | $2.7B+18.4% | $2.8B+27.2% | $2.9B+22.3% | $2.3B+10.6% | $2.3B+12.7% | $2.2B-7.1% | $2.3B+5.9% | $2.1B-3.2% |
| Non-Current Liabilities | $4.0B+10.4% | $3.0B-11.1% | $3.0B-7.5% | $3.6B+5.5% | $3.6B+6.1% | $3.3B-1.5% | $3.3B-12.2% | $3.4B-11.7% |
| Long-Term Debt | $2.4B+24.2% | $1.4B-28.7% | $1.4B-28.8% | $1.9B-3.2% | $1.9B-2.7% | $2.0B-0.6% | $2.0B-12.8% | $2.0B-12.3% |
| Total Equity | $10.4B-5.9% | $11.0B+1.4% | $11.5B+7.9% | $11.2B+5.8% | $11.1B+7.1% | $10.8B+6.1% | $10.6B+4.7% | $10.6B+6.7% |
| Retained Earnings | $4.0B+18.5% | $3.8B+18.2% | $3.7B+18.0% | $3.5B+19.5% | $3.3B+20.4% | $3.2B+20.4% | $3.1B+20.7% | $2.9B+20.1% |
XYL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $290.0M-4.9% | $108.0M+227.3% | $543.0M-5.6% | $360.0M+15.8% | $305.0M+5.9% | $33.0M-62.9% | $575.0M+26.4% | $311.0M-16.6% |
| Depreciation & Amortization | $140.0M-3.4% | $140.0M-3.4% | $143.0M+0.7% | $142.0M+0.7% | $145.0M0.0% | $145.0M+8.2% | $142.0M+3.6% | $141.0M-4.1% |
| Stock-Based Compensation | $12.0M-7.7% | $13.0M+8.3% | N/A | $12.0M0.0% | $13.0M0.0% | $12.0M-33.3% | N/A | $12.0M-33.3% |
| Capital Expenditures | $89.0M-9.2% | $90.0M+26.8% | $83.0M-17.0% | $79.0M+6.8% | $98.0M+34.2% | $71.0M-4.1% | $100.0M+6.4% | $74.0M0.0% |
| Free Cash Flow | $201.0M-2.9% | $18.0M+147.4% | $460.0M-3.2% | $281.0M+18.6% | $207.0M-3.7% | -$38.0M-353.3% | $475.0M+31.6% | $237.0M-20.7% |
| Investing Cash Flow | -$22.0M+82.4% | -$76.0M-406.7% | -$142.0M+50.9% | -$189.0M-190.8% | -$125.0M-62.3% | -$15.0M+70.6% | -$289.0M-224.7% | -$65.0M-30.0% |
| Financing Cash Flow | $199.0M+255.5% | -$683.0M-488.8% | -$119.0M-25.3% | -$138.0M-36.6% | -$128.0M+62.0% | -$116.0M-41.5% | -$95.0M-10.5% | -$101.0M+67.0% |
| Dividends Paid | $101.0M+3.1% | $106.0M+8.2% | $98.0M+12.6% | $97.0M+10.2% | $98.0M+12.6% | $98.0M+11.4% | $87.0M+8.8% | $88.0M+10.0% |
| Share Buybacks | $680.0M | $563.0M+4230.8% | $1.0M0.0% | $1.0M0.0% | $0-100.0% | $13.0M-13.3% | $1.0M-93.3% | $1.0M0.0% |
XYL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 41.2%+2.5pp | 37.8%+0.7pp | 38.9%+0.9pp | 38.9%+1.7pp | 38.8%+1.0pp | 37.1%+0.1pp | 38.0%+2.3pp | 37.3%+0.5pp |
| Operating Margin | 16.7%+3.4pp | 11.5%+0.3pp | 14.7%+2.9pp | 14.7%+1.4pp | 13.3%+1.6pp | 11.2%+0.9pp | 11.8%+1.9pp | 13.3%+4.1pp |
| Net Margin | 11.3%+1.4pp | 9.1%+0.9pp | 14.0%-0.5pp | 10.0%-0.3pp | 9.8%+0.9pp | 8.2%+0.6pp | 14.4%+1.9pp | 10.3%+3.0pp |
| Return on Equity | 2.5%+0.5pp | 1.8%+0.2pp | 2.9%-0.1pp | 2.0%0.0pp | 2.0%+0.2pp | 1.6%+0.1pp | 3.1%+0.4pp | 2.1%+0.5pp |
| Return on Assets | 1.5%+0.2pp | 1.1%+0.1pp | 1.9%-0.1pp | 1.3%0.0pp | 1.3%+0.1pp | 1.0%+0.1pp | 2.0%+0.3pp | 1.4%+0.4pp |
| Current Ratio | 1.61-0.3x | 1.46-0.4x | 1.63-0.1x | 1.960.0x | 1.900.0x | 1.89+0.2x | 1.750.0x | 1.96+0.2x |
| Debt-to-Equity | 0.23+0.1x | 0.13-0.1x | 0.12-0.1x | 0.170.0x | 0.170.0x | 0.180.0x | 0.190.0x | 0.190.0x |
| Asset Turnover | 0.130.0x | 0.130.0x | 0.140.0x | 0.130.0x | 0.130.0x | 0.120.0x | 0.140.0x | 0.130.0x |
| FCF Margin | 8.6%-0.4pp | 0.9%+2.7pp | 19.2%-1.9pp | 12.4%+1.1pp | 9.0%-0.9pp | -1.8%-2.6pp | 21.1%+4.0pp | 11.3%-3.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Xylem Inc XYL | FY2025 | $9.0B | $957.0M | 10.6% | $24.0B | 68/100 |
| Otis Worldwide Corporation OTIS | FY2025 | $14.4B | $1.4B | 9.6% | $25.1B | 53/100 |
| Rockwell Automation, Inc. ROK | FY2025 | $8.3B | $869.0M | 10.4% | $48.0B | 58/100 |
| Ingersoll Rand Inc. IR | FY2025 | $7.7B | $581.4M | 7.6% | $30.6B | 61/100 |
| Ametek, Inc. AME | FY2025 | $7.4B | $1.5B | 20.0% | $57.0B | 69/100 |
| Dover Corporation DOV | FY2025 | $8.1B | $1.1B | 13.5% | $25.4B | 64/100 |
Where Xylem Inc Ranks
Frequently Asked Questions
What is Xylem Inc's annual revenue?
Xylem Inc (XYL) reported $9.0B in total revenue for fiscal year 2025. This represents a 5.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Xylem Inc's revenue growing?
Xylem Inc (XYL) revenue grew by 5.5% year-over-year, from $8.6B to $9.0B in fiscal year 2025.
Is Xylem Inc profitable?
Yes, Xylem Inc (XYL) reported a net income of $957.0M in fiscal year 2025, with a net profit margin of 10.6%.
What is Xylem Inc's EBITDA?
Xylem Inc (XYL) had EBITDA of $1.8B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Xylem Inc have?
As of fiscal year 2025, Xylem Inc (XYL) had $1.5B in cash and equivalents against $1.4B in long-term debt.
What is Xylem Inc's gross margin?
Xylem Inc (XYL) had a gross margin of 38.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Xylem Inc's operating margin?
Xylem Inc (XYL) had an operating margin of 13.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Xylem Inc's net profit margin?
Xylem Inc (XYL) had a net profit margin of 10.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Xylem Inc pay dividends?
Yes, Xylem Inc (XYL) paid $1.60 per share in dividends during fiscal year 2025.
What is Xylem Inc's return on equity (ROE)?
Xylem Inc (XYL) has a return on equity of 8.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Xylem Inc's free cash flow?
Xylem Inc (XYL) generated $910.0M in free cash flow during fiscal year 2025. This represents a -3.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Xylem Inc's operating cash flow?
Xylem Inc (XYL) generated $1.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Xylem Inc's total assets?
Xylem Inc (XYL) had $17.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Xylem Inc's capital expenditures?
Xylem Inc (XYL) invested $331.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Xylem Inc spend on research and development?
Xylem Inc (XYL) invested $226.0M in research and development during fiscal year 2025.
What is Xylem Inc's current ratio?
Xylem Inc (XYL) had a current ratio of 1.63 as of fiscal year 2025, which is generally considered healthy.
What is Xylem Inc's debt-to-equity ratio?
Xylem Inc (XYL) had a debt-to-equity ratio of 0.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Xylem Inc's return on assets (ROA)?
Xylem Inc (XYL) had a return on assets of 5.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Xylem Inc's P/E ratio?
Xylem Inc (XYL) trades at 23.6x earnings, its market capitalization divided by net income of $1.0B net income, trailing 12 months to June 30, 2026. The market capitalization is $24.0B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Xylem Inc's price-to-sales ratio?
Xylem Inc (XYL) trades at 2.6x sales, its market capitalization divided by revenue of $9.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $24.0B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Xylem Inc's Altman Z-Score?
Xylem Inc (XYL) has an Altman Z-Score of 3.60, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Xylem Inc's Piotroski F-Score?
Xylem Inc (XYL) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Xylem Inc's earnings high quality?
Xylem Inc (XYL) has an earnings quality ratio of 1.30x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Xylem Inc cover its interest payments?
Xylem Inc (XYL) has an interest coverage ratio of 42.17x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Xylem Inc?
Xylem Inc (XYL) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.